EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial

Mikel Sarasate, Nuria González, Ana Córdoba-Izquierdo, Enric Prats, Jose Miguel Rodriguez Gonzalez-Moro, Sergi Martí, Manel Lujan, Myriam Calle, Antonio Antón, Mónica Povedano, Eva Farrero

Journal of Neuromuscular Diseases · 04.07.2023 · 10 (4) · 627-637

DOI: 10.3233/jnd-221658 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 13.05.2023. Verfasst von Mikel Sarasate und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, UFIS-Respiratoria, Hospital Universitari de Bellvitge, Barcelona, Spain. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Noninvasive Ventilation. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective: Forced vital capacity (FVC) less than 50% of predicted is one of the main parameters used for Non-Invasive Ventilation (NIV) initiation in Amyotrophic Lateral Sclerosis (ALS). Recent studies suggest that higher values of FVC could be considered as a threshold. The aim of this study is to evaluate whether early use of NIV improves the prognosis of ALS patients compared with standard initiation.

Methods

This is a randomized, parallel, multicenter, open-label, controlled clinical trial, with recruitment at the ALS outpatient multidisciplinary units of six Spanish hospitals. Patients were included when their FVC reached the 75% threshold and were randomized by computer, stratifying by center in an allocation ratio of 1:1 to Early NIV (FVC below 75%) or Standard NIV (FVC below 50%) initiation. The primary outcome was time to death or tracheostomy. Trial registration number ClinicalTrials.gov: NCT01641965.

Results

Between May 2012 and June 2014, 42 patients were randomized to two groups, 20 to Early NIV and 22 to Standard NIV initiation. We found differences in survival in favor of the intervention group: an incidence of mortality (2.68 [1.87–5.50] vs. 3.33 [1.34–4.80] person-months) and a median survival (25.2 vs. 19.4 months), although without reaching statistical significance ( p = 0.267).

Conclusions

This trial did not reach the primary endpoint of survival; nevertheless, it is the first Randomized Controlled Trial (RCT) to demonstrate the benefits of early NIV in slowing the decline of respiratory muscle strength and reducing adverse events. Although not all the results reached statistical significance, all the analyzed data favor early NIV. In addition, this study demonstrates good tolerance and compliance with early NIV without quality of sleep impairment. These data reinforce the early respiratory evaluation of ALS patients and NIV initiation with an FVC of around 75%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNoninvasive VentilationHumansRespiration, ArtificialVital CapacityPatient Compliance

Stichwörter der Autor:innen

ALSEarly NIVrespiratory complicationsrespiratory insufficiencysurvival

Autor:innen und Institutionen

  • Department of Pneumology, UFIS-Respiratoria, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Department of Pneumology, Hospital Residencia Sant Camil, Consorci Sanitari Alt Pendedés-Garraf, Barcelona, Spain.
  • Department of Pulmonology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Department of Respiratory Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Departament de Medicina, Universita…
  • Department of Pneumology, Corporació Sanitaria Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Department of Pneumology, Hospital Clínico San Carlos, Department of Medicine, Faculty of Medicine, Complutense University of Madrid, San Carlos Clinical Hospital Institute of Health Research (IdISSC), Madrid, Spain.

Zitieren

APA

Sarasate, M., González, N., Córdoba-Izquierdo, A., Prats, E., Gonzalez-Moro, J. M. R., Martí, S., Lujan, M., Calle, M., Antón, A., Povedano, M., & Farrero, E. (2023). Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial. Journal of Neuromuscular Diseases, 10(4), 627-637. https://doi.org/10.3233/jnd-221658

Vancouver

Sarasate M, González N, Córdoba-Izquierdo A, Prats E, Gonzalez-Moro JMR, Martí S, et al. Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial. Journal of Neuromuscular Diseases. 2023;10(4):627-637. doi:10.3233/jnd-221658

BibTeX
@article{Sarasate2023,
  author = {Sarasate, Mikel and González, Nuria and Córdoba-Izquierdo, Ana and Prats, Enric and Gonzalez-Moro, Jose Miguel Rodriguez and Martí, Sergi and Lujan, Manel and Calle, Myriam and Antón, Antonio and Povedano, Mónica and Farrero, Eva},
  title = {Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial},
  journal = {Journal of Neuromuscular Diseases},
  year = {2023},
  volume = {10},
  number = {4},
  pages = {627--637},
  doi = {10.3233/jnd-221658}
}
Kostenlos starten →